Pancreatic Cancer News

---

Our group is open to people living with a pancreatic cancer diagnosis and their loved ones. We aim to provide an open and accepting space to share experiences, questions, fears and support with others who "get it." Topics include coping strategies, treatment planning, diet, supplemental medicine and relationships.

The newly released American Cancer Society Cancer Facts & Figures 2026 underscores the urgent need for improved detection and treatment for pancreatic cancer. This year, an estimated 67,530 Americans will be diagnosed and 52,740 will die from the disease. Incidence continues to rise by about 1% each year.

Because there is no recommended screening for the general population, pancreatic cancer is often diagnosed late, when it’s harder to treat. The overall 5-year survival rate is 13%, and only 17% of patients are diagnosed when the cancer is still localized—where outcomes improve significantly compared to later stages.

We share these facts not to discourage, but to educate, advocate, and bring hope through awareness, research, and earlier detection for those at highest risk. These numbers highlight why advocacy, research, clinical trials, and awareness matter so deeply to the pancreatic cancer community.

Living Hope remains committed to sharing stories, elevating science, and keeping hope alive for patients, families, survivors, and caregivers.

Dr. Jonathan Kessler, chief of interventional radiology at City of Hope, says the new device may change that.

“With this device, we’re giving 100% of the therapy directly to the tumor,” he said. “We expect fewer side effects and better outcomes because none of it is wasted in parts of the body that don’t have cancer.”

The treatment is now available to qualifying patients.

  "Early Detection and Better Treatments:  How Testing Plays a Critical Role took place on  on Thursday, Nov. 18, 2021.  Please click link below to watch the pre recorded program.

 It’s been 10 years since legendary Apple Inc., Co-founder Steve Jobs passed away at only 56 years old after battling pancreatic neuroendocrine tumor, a rare form of

 pancreatic cancer. 

 Pancreatic neuroendocrine tumors (or PNETs) account for only 7% of all pancreatic cancer tumors and tend to grow slower than exocrine tumors, the most common type of pancreas tumors. Jobs survived eight years before dying of the disease on Oct. 5, 2011. 

There are now two blood-based tests available that can potentially detect cancer before it causes symptoms or is diagnosed through other methods. 

  Jamie Foltz, who lost her mother to pancreatic cancer, spoke with two longtime PanCAN supporters, both pancreatic cancer survivors, Roberta Luna, Orange County Affiliate and Matt Wilson, Delaware Affiliate on the subject. 

 19-year Survivor Roberta Luna and her husband Vic embark on a new journey with OC Talk Radio.